NORDIC BIOTECH K/S: Financial statements 2016
CVR: 26290724
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
NORDIC BIOTECH K/S (CVR 26290724) has filed annual accounts for 2016. In 2016, the company reported a net result of DKK -1,098,813,000 compared with DKK 317,378,000 the year before. Equity in the 2016 report amounted to DKK 2,266,804,000. The solvency ratio was 100%.
- Profit/Loss
- DKK -1,098,813,000
- Equity
- DKK 2,266,804,000
- Total Assets
- DKK 2,267,287,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | - | -1.1B | 2.3B | - |
| 2015 | - | - | 317.4M | 3.4B | - |
| 2014 | - | -44K | 2B | 3B | - |
| 2013 | - | -2.8M | 302.5M | 1B | - |
| 2012 | - | - | 571.2M | 723.8M | - |
Official annual report
Find more companies like NORDIC BIOTECH K/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
NORDIC BIOTECH K/S has published its annual report for 2015. The net result was DKK 317,378,000.
About NORDIC BIOTECH K/S
NORDIC BIOTECH K/S was a Danish company of the type Kommanditselskab based in Hellerup, founded in 2001. The company has been dissolved on 22 December 2025. The company was registered under the industry Anden finansiel formidling i.a.n.. The company has 0 employees (2011). In 2024, the company reported a gross profit of DKK -157,000 and a net result of DKK 101,458,000 compared with DKK 1,254,000 the year before. Equity in the 2024 report amounted to DKK 127,032,000.